Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WDR45 variants cause ferrous iron loss due to impaired ferritinophagy associated with nuclear receptor coactivator 4 and WD repeat domain phosphoinositide interacting protein 4 reduction. | Brain Commun | 2022 | 36751498 | PubTator, text mining | PubMed |
| Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. | Front Immunol | 2022 | 36713430 | PubTator, text mining | PubMed |
| Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma. | Front Genet | 2022 | 36704353 | PubTator, text mining | PubMed |
| IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts. | Front Immunol | 2022 | 36700205 | PubTator, text mining | PubMed |
| Structural basis for ubiquitylation by HOIL-1. | Front Mol Biosci | 2022 | 36685275 | PubTator, text mining | PubMed |
| Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract. | Natl J Maxillofac Surg | 2022 | 36683943 | PubTator, text mining | PubMed |
| EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models. | Front Cell Infect Microbiol | 2022 | 36683690 | PubTator, text mining | PubMed |
| Proteomic Characterization of PAMs with PRRSV-ADE Infection. | Viruses | 2022 | 36680075 | PubTator, text mining | PubMed |
| Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. | Medicina (Kaunas) | 2022 | 36676626 | PubTator, text mining | PubMed |
| Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. | Genes (Basel) | 2022 | 36672784 | PubTator, text mining | PubMed |
| AIM™ platform: A new immunotherapy approach for viral diseases. | Front Med (Lausanne) | 2022 | 36619639 | PubTator, text mining | PubMed |
| Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma. | Front Immunol | 2022 | 36618352 | PubTator, text mining | PubMed |
| Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 36615128 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis. | Int J Mol Sci | 2022 | 36613688 | PubTator, text mining | PubMed |
| 5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 36612115 | PubTator, text mining | PubMed |
| Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. | J Immunother Cancer | 2022 | 36600602 | PubTator, text mining | PubMed |
| Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches. | Exp Hematol Oncol | 2022 | 36575540 | PubTator, text mining | PubMed |
| Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson's Disease: Recent Advancement. | Oxid Med Cell Longev | 2022 | 36567855 | PubTator, text mining | PubMed |
| Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus. | Viruses | 2022 | 36560713 | PubTator, text mining | PubMed |
| EBV Association with Lymphomas and Carcinomas in the Oral Compartment. | Viruses | 2022 | 36560704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=28